Enteric coating of aspirin substantially reduces gastric mucosa damage
Dammann, H.G.; Seiberling, R.; Hafner, A.; Burkhardt, F.; Wolf, N.; Walter, T.A.
Gastroenterology 110(4 Suppl): A88
1996
ISSN/ISBN: 0016-5085 Accession: 031256537
PDF emailed within 1 workday: $29.90
Related References
Cole, A.T.; Hudson, N.; Liew, L.C.; Murray, F.E.; Hawkey, C.J.; Heptinstall, S. 1999: Protection of human gastric mucosa against aspirin-Enteric coating or dose reduction? Alimentary Pharmacology and Therapeutics 13(2): 187-193Hawthorne, A.B.; Hurst, S.M.; Mahida, Y.R.; Cole, A.T.; Daneshmend, T.K.; Hawkey, C.J. 1990: Enteric coating of aspirin eliminates gastric mucosal damage despite inhibition of prostaglandin synthesis Gastroenterology 98(5 Part 2): A56
Hawthorne, A.B.; Mahida, Y.R.; Cole, A.T.; Hawkey, C.J. 1991: Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis British Journal of Clinical Pharmacology 32(1): 77-83
Lanza, F.L.; Royer, G.L.; Nelson, R.S. 1980: Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa New England Journal of Medicine 303(3): 136-138
Anslow, J.A.; Balm, T.K.; Hooper, J.W.; Szego, P.; Wagner, G.S. 1985: Minimization of gastric damage with enteric-coated aspirin granules compared to buffered aspirin Pharmacology 30(1): 40-44
Whellan, D.J.; Goldstein, J.L.; Cryer, B.L.; Eisen, G.M.; Lanas, A.; Miller, A.B.; Scheiman, J.M.; Fort, J.G.; Zhang, Y.; O'Connor, C. 2014: PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies American Heart Journal 168(4): 495-502.E4
Garner, A. 1977: Assessment of gastric mucosal damage: comparative effects of aspirin and fenclofenac on the gastric mucosa of the guinea pig Toxicology and Applied Pharmacology 42(3): 477-486
Fiorucci, S.; Antonelli, E.; Morelli, O.; Federici, B.; Morelli, A. 1998: Prevention of gastric damage by NO-releasing aspirin is mediated by inhibition of ICE/-like proteases in gastric mucosa and endothelial cells Gastroenterology 114(4 Part 2): A122
Konturek, S.J.; Kwiecien, S.; Brzozowski, T.M.; Karczewska, E.; Duda, A.; Konturek, P.C.; Moran, A.; Hahn, E. 2002: Gastric adaptation to H pylori-lipopolysaccharide and intestinal bacterial LPS enhances resistance of gastric mucosa to aspirin damage Gastroenterology 122(4 Suppl 1): A-423
Graham, D.Y.; Moon, N. 1999: Low-dose aspirin may or may not damage the gastric mucosa Gastroenterology 117(6): 1505
Adams, M.W.; Wu, S.H. Wei 2000: Aqueous enteric coating composition and low gastric permeability enteric coating Official Gazette of the United States Patent and Trademark Office Patents 1239(5)
Shoemaker, R.L. 1972: Micro electrode studies of aspirin damage to gastric mucosa Gastroenterology: 804
Svanes, K.; Leiknes, K.A.; Varhaug, J.E.; Søreide, O. 1979: Aspirin damage to ischemic gastric mucosa in shocked cats Scandinavian Journal of Gastroenterology 14(5): 633-639
Fan, D.-D.; Lin, S.; Song, Y.-P.; Wang, Z.-Y.; Liu, B.; Gao, S.-N.; Fan, Y.-H.; Zhu, S.; Li, S.; Jiang, L. 2016: Astragaloside IV protects rat gastric mucosa against aspirin-induced damage International Immunopharmacology 41: 47-55
Ligumsky, M.; Hansen, D.G.; Kauffman, G.L. 1982: Salicylic acid reduces indomethacin and aspirin induced cyclo oxygenase inhibition in the gastric mucosa Gastroenterology 82(5 Part 2): 1118